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Background
Immunogenic properties of the CombiHIVvac, compris-
ing polyepitopeHIV-1 immunogens, one being the artifi-
cial polyepitope protein TBI, containing the T- and B-cell
epitopes from Env and Gag proteins, and the DNA vaccine
construct pcDNA-TCI coding for the artificial protein TCI,
carrying over 80 T-cell epitopes (both CD4+ CTL and
CD8+ Th) from Env, Gag, Pol, and Nef proteins, are stud-
ied in this work.
Methods
The vaccine constructs containing the immunogens TCI
and TBI were produced using VLP technology. Several var-
iants of these constructs were designed. The first variant is
the candidate vaccine CombiHIVvac, the artificial micelle-
like particles VLP-TBI-pcDNA-TCI The other two variants
were the artificial micelle-like particles VLP-TBI-pcDNA
and VLP-pcDNA-TCI, which were produced similarly to
VLP-TBI-pcDNA-TCI, except that the vector plasmid
pcDNA3.1. For control purposes, a construct consisting of
the vector pcDNA3.1 coated with a spermidine-polyglu-
cin conjugate was used. The conjugate was synthesized as
described above except for TBI protein was not added to
the reaction mixture.
Results
The data reported demonstrate clearly that a combination
of two B- and T-cell immunogens (TBI and TCI) in one
construct results in a synergistic increase in the antibody
response to both TBI protein and the proteins from HIV-1
lysate. The level of antibodies induced by immunization
with the constructs containing either immunogen alone
(TBI protein or the plasmid pcDNA-TCI) was significantly
lower as compared to that induced by the combined vac-
cine.
Conclusion
The analysis performed suggests that the presence of
CD4+ T-helper epitopes, which can be presented by MHC
class II, in the protein TCI, may be the main reason under-
lying the increased synthesis of antibodies to TBI protein
due to a CD4-mediated stimulation of B-cell proliferation
and differentiation.
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